The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hannah Brendan since 2023.
This trader's CIK number is 1929422.
At the time of last reporting, Hannah Brendan was the CHIEF BUSINESS OFFICER AND COO of Quince Therapeutics, Inc.. (stock ticker symbol QNCX).
Also see all insider trading activities at Quince Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | QNCX | 38,924 | $23,956 | 0 | $0 | 56,061 | $30,833 |
| 2023 | QNCX | 71,762 | $87,549 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-21 | QNCX | Buy | 30,845 | .62 | 19,123 |
| 2024-08-20 | QNCX | Buy | 5,924 | .60 | 3,584 |
| 2024-08-19 | QNCX | Buy | 2,155 | .58 | 1,249 |
| 2024-06-04 | QNCX | Option Ex | 56,061 | .55 | 30,833 |
| 2023-08-08 | QNCX | Buy | 71,762 | 1.22 | 87,549 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hannah Brendan (CHIEF BUSINESS OFFICER AND COO of Quince Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.